Generation of induced pluripotent stem cells from an HLA-B27 positive ankylosing spondylitis patient with syndesmophyte formation

Stem Cell Res. 2024 Oct:80:103508. doi: 10.1016/j.scr.2024.103508. Epub 2024 Jul 25.

Abstract

Human leukocyte antigen (HLA)-B27 is the genetic marker for ankylosing spondylitis (AS). Here, we generated induced pluripotent stem cells (iPSCs) from peripheral blood mononuclear cells of a male AS patient carrying HLA-B27 with syndesmophyte formation by using the Sendai-virus delivery system. The resulting iPSCs had a normal karyotype, expressed pluripotent markers, and could differentiate into three germ layers. This cellular model will provide a platform for studying pathological mechanisms of new bone formation in HLA-B27 positive AS patients.

MeSH terms

  • Adult
  • Cell Differentiation
  • HLA-B27 Antigen* / genetics
  • HLA-B27 Antigen* / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Spondylitis, Ankylosing* / genetics
  • Spondylitis, Ankylosing* / metabolism
  • Spondylitis, Ankylosing* / pathology

Substances

  • HLA-B27 Antigen